HISTIOCYTOSIS ASSOCIATION INC
Income Statement
Fiscal Year: 2024
Jan 1, 2024 – Dec 31, 2024
Revenues in 2024
$1,241,274
Fundraising Events
66%
Contributions
21%
Investments
11%
Program Services
2%
Other
<1%
Government Grants
0%
Membership Dues
0%
Expenses in 2024
$1,287,139
Salaries & Benefits
39%
Other
30%
Grants
20%
Offices, Occupancy & IT
5%
Fees to Service Providers
4%
Depreciation
<1%
Advertising & Promotion
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$242,323
$265,906
+10%
Government Grants
$98,000
$0
-100%
Fundraising Events
$805,669
$813,268
+1%
Program Services
$50,580
$20,000
-60%
Membership Dues
$0
$0
-
Investments
$31,995
$141,766
+343%
Other
$2,467
$334
-86%
Total Revenues
$1,231,034
$1,241,274
+1%
Expenses
2023
2024
Change
Grants
$234,600
$261,388
+11%
Benefits to Members
$0
$0
-
Salaries & Benefits
$510,343
$506,243
-1%
Fees to Service Providers
$37,961
$55,838
+47%
Advertising & Promotion
$9,189
$4,296
-53%
Offices, Occupancy & IT
$56,079
$70,089
+25%
Interest
$0
$0
-
Depreciation
$0
$8,505
-
Other
$330,822
$380,780
+15%
Total Expenses
$1,178,994
$1,287,139
+9%
Net income
2023
2024
Change
Net income
+$52,040
-$45,865
-188%
Functional Expenses
Summary
2023
2024
Change
Program
$1,031,852
$1,119,607
+9%
Admin
$57,229
$64,292
+12%
Fundraising
$89,913
$103,240
+15%
Total Expenses
$1,178,994
$1,287,139
+9%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)